Form 4 for GH Guardant Health, Inc.
Accepted 2025-01-16 00:00:00 ET · period of report 2025-01-15 · accession 0001576280-25-000024 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-16 | 2025-01-15 | GH | Monroe Terilyn J. | CHRO | F - Tax | $37.50 | -6,420 | 11.9K | -35% | -$240.8K |
| D | 2025-01-16 | 2025-01-15 | GH | Monroe Terilyn J. | CHRO | M - OptEx | $0.00 | +17.4K | 18.3K | +1,792% | $0 |
| D | 2025-01-16 | 2025-01-15 | GH | Monroe Terilyn J. | CHRO | M - OptEx | $0.00 | -17.4K | 34.8K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-15 | F | D | 6,420 | $37.50 | 11,928 | D | — | — | (F1) These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| 2 | Common | Common Stock | 2025-01-15 | M | A | 17,378 | $0.00 | 18,348 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2025-01-15 | M | D | 17,378 | $0.00 | 34,758 | D | $0.00 · — to — | 17,378 Common Stock | (F2) This represents a restricted stock unit award granted on February 26, 2024 that vests over a three-year period. 33% of the shares subject to such award vests on the one-year anniversary of January 15, 2024 and the remaining 67% of the shares vests annually over the remaining two-year period thereafter. (F3) Not applicable for Restricted Stock Units. |